Moderna, Inc.
MRNA
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influe...
AI Summary
| Model | Near-Term (0-3 mo.) | Mid-Term (3-12 mo.) | Long-Term (1-5 yr.) |
|---|---|---|---|
| Deepseek | Hold | Buy | Buy |
| OpenAI | Buy | Hold | Hold |
| Gemini | Buy | Hold | Hold |
| Grok | Buy | Hold | Sell |
Detailed Analysis
High volatility and negative PE suggest caution in the short term.
Potential for recovery as market conditions stabilize and company progresses.
Strong sector position and innovation potential support long-term growth.
Price above 50-day average suggests upward momentum, but negative P/E raises concerns.
High beta indicates volatility; hold until clearer earnings and pipeline progress.
Long-term potential depends on successful pipeline and market diversification beyond COVID.
Recent price surge suggests a short-term upward momentum.
Uncertainty in sustained growth or profitability in the medium term.
Long-term potential but dependent on significant strategic shifts.
Current price above 50-day average suggests upward momentum. Potential for short-term gains.
Price below 200-day average signals potential weakness. High beta suggests volatility.
Negative valuation and high beta indicate sustained risk. Long-term profitability uncertain.